{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:48:59Z","timestamp":1761994139533,"version":"build-2065373602"},"reference-count":104,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.cancergen.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T12:38:23Z","timestamp":1471264703000},"page":"559-566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A practical approach to liver metastasis from unknown primary cancer: What surgeons need to know"],"prefix":"10.1016","volume":"209","author":[{"given":"Forat","family":"Swaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell","family":"Downs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Rosemurgy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2016.08.004_bib0010","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1200\/JCO.1995.13.8.2094","article-title":"Analysis of a diag- nostic strategy for patients with suspected tumors of unknown origin","volume":"13","author":"Abbruzzese","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/1097-0339(200011)23:5<326::AID-DC8>3.0.CO;2-1","article-title":"Fine-needle aspiration biopsy of the liver: a multicenter study of 602 radiologically guided FNA","volume":"23","author":"Hertz","year":"2000","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0020","first-page":"74","article-title":"Global cancer statis- tics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000325951","article-title":"HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepa- tocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates","volume":"50","author":"Wang","year":"2006","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dc.10345","article-title":"Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytol- ogy","volume":"30","author":"Saad","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cncr.10309","article-title":"Diagnostic utility of Glut-1 and CA 15-3 in discriminat- ing adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration","volume":"96","author":"Zimmerman","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0040","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/cncr.9043","article-title":"Diagnostic value of hepatocytes paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic car- cinoma in fine-needle aspiration biopsies of the liver","volume":"93","author":"Zimmerman","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0045","series-title":"Cancer: Principles and Practice of Oncology","first-page":"2033","article-title":"Cancerofunknown primary","author":"Greco","year":"2011"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-5876-10-12","article-title":"Cancers of unknown primary origin: current perspectives and future therapeutic strategies","volume":"10","author":"Stella","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0055","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.ejca.2007.06.023","article-title":"Switching benchmarks in cancer of unknown primary: from autopsy to microarray","volume":"43","author":"Pentheroudakis","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMra1303917","article-title":"Cancerof unknown primary site","volume":"371","author":"Varadhachary","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0065","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ctrv.2013.03.001","article-title":"Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature","volume":"39","author":"Petrakis","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0070","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1200\/JCO.2007.14.4378","article-title":"Molecular profiling of carcinoma of unknown primary and corre- lation with clinical evaluation","volume":"26","author":"Varadhachary","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0075","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/radiol.2312021185","article-title":"Clinical applications of PET in oncology","volume":"231","author":"Rohren","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0080","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1002\/1097-0142(19940615)73:12<3047::AID-CNCR2820731225>3.0.CO;2-#","article-title":"Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers","volume":"73","author":"Rege","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.oraloncology.2008.05.010","article-title":"Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors","volume":"45","author":"Roh","year":"2009","journal-title":"Oral Oncol"},{"issue":"suppl 1","key":"10.1016\/j.cancergen.2016.08.004_bib0090","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s00259-008-1016-6","article-title":"Multimodality imaging: an update on PET\/CT technology","volume":"36","author":"Mawlawi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00259-009-1295-6","article-title":"FDG PET\/CT in carcinoma of unknown primary","volume":"37","author":"Kwee","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0100","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1634\/theoncologist.2011-0449","article-title":"A prospective comparison of 18F-FDG PET\/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site","volume":"17","author":"M\u00f8ller","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ajcp\/86.3.281","article-title":"Fine-needle aspiration of the liver. A comparison of smear and rinse preparations in the detection of can- cer","volume":"86","author":"Axe","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jcp.55.2.93","article-title":"Comparison of fine needle aspiration cytology and needle core biopsy in the diagnosis of radiologically detected abdominal lesions","volume":"55","author":"Stewart","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0115","first-page":"152","article-title":"Coarse needle biopsy ver- sus fine needle aspiration biopsy in the diagnosis of focal lesions of the liver: ultrasonically guided needle biopsy in suspected hepatic malignancy","volume":"27","author":"Jacobsen","year":"1983","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0120","first-page":"62","article-title":"Is the Tru-Cut needle more efficient than the fine needle in the diagnosis of hepatic lesions? Compara- tive study of 45 echography-guided punctures","volume":"14","author":"Bedenne","year":"1990","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/030089168807400321","article-title":"Fine aspiration versus fine cutting needle, and comparison between smear cytology, inclusion cytology and microhistology in abdominal lesions","volume":"74","author":"Livraghi","year":"1988","journal-title":"Tumori"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0130","first-page":"476","article-title":"Comparison of cytologic examination of smears and histologic examination of tissue cores obtained by fine needle aspiration biopsy of the liver","volume":"31","author":"Cochand-Priollet","year":"1987","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1440-1673.1991.tb02988.x","article-title":"Ultrasound guided fine needle biopsy of the liver for cytology and histology","volume":"35","author":"Lin","year":"1991","journal-title":"Australas Radiol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0140","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF02498807","article-title":"Comparison between echo- guided fine-needle aspiration cytology and microhistology in diagnosing pancreatic masses","volume":"6","author":"Solmi","year":"1992","journal-title":"Surg Endosc"},{"volume":"Vol. 31","year":"2001","key":"10.1016\/j.cancergen.2016.08.004_bib0145"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jcp.54.3.196","article-title":"The usefulness of tyrosi- nase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A)","volume":"54","author":"Clarkson","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.3880336","article-title":"Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a ret- rospective analysis of the utility of cytomorphology and flow cytometry","volume":"14","author":"Dong","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/dc.2840090303","article-title":"Immunophenotyping of cytologic specimens by flow cytometry","volume":"9","author":"Moriarty","year":"1993","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0339(199908)21:2<98::AID-DC4>3.0.CO;2-V","article-title":"Fine-needle aspiration with flow cytometric immunophenotyping for primary diagnosis of intra-abdominal lymphomas","volume":"21","author":"Liu","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cncr.9042","article-title":"Cytologic diagnosis of gastrointestinal stromal tumor with emphasis on the differential diagnosis with leiomyosarcoma","volume":"93","author":"Wieczorek","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/dc.20199","article-title":"Fine-needle aspiration cytology of metastatic transitional cell carcinoma","volume":"32","author":"Dey","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2559.2000.00890.x","article-title":"Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroen- docrine carcinomas of various primary sites","volume":"36","author":"Kaufmann","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.critrevonc.2004.10.002","article-title":"Cancer of unknown primary (CUP)","volume":"54","author":"Pavlidis","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0190","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.20202","article-title":"Diagnostic strategies for unknown primary cancer","volume":"100","author":"Varadhachary","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0195","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00000478-200110000-00011","article-title":"Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas","volume":"25","author":"Borscheri","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0200","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1309\/KC09YTF2M4DLUYQ6","article-title":"Hepatocyte paraffin 1 expression in human normal and neoplastic tissues","volume":"122","author":"Lugli","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0205","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00000478-200208000-00002","article-title":"Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carci- noembryonic antigen, CD10, and alpha-fetoprotein","volume":"26","author":"Chu","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0210","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3346\/jkms.2003.18.6.842","article-title":"Hepatocyte expressions in he- patocellular carcinomas, gastrointestinal neoplasms, and non-neoplastic gastrointestinal mucosa: its role as a diag- nostic marker","volume":"18","author":"Lee","year":"2003","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0215","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1309\/KKDP-MND2-W794-P9EH","article-title":"Com- parison of thyroid transcription factor-1 and heparocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adeno- carcinoma, renal cell carcinoma, and adrenal cortical carci- noma","volume":"118","author":"Wieczorek","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0220","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cncr.22768","article-title":"Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies","volume":"111","author":"Onofre","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/path.1711560405","article-title":"Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections","volume":"156","author":"Balaton","year":"1988","journal-title":"J Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0230","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.3880134","article-title":"Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 com- pares favorably with other putative markers","volume":"13","author":"Porcell","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00129039-200006000-00006","article-title":"MOC31 immunoreactivity in primary and metastatic carcinoma of the liver: report of findings and review of other utilized markers","volume":"8","author":"Proca","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0240","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/hupa.2002.130104","article-title":"Comparative immunohisto- chemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma","volume":"33","author":"Lau","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5858\/2002-126-0170-AIITDO","article-title":"A103 immunostaining in the diag- nosis of adrenal cortical tumors: an immunohistochemical study of 316 cases","volume":"126","author":"Loy","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0250","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1309\/QFFN-6808-M4G5-UA1K","article-title":"Diagnostic utility of the monoclonal antibody A103 in fine-needle aspiration biopsies of the adrenal","volume":"113","author":"Shin","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0255","first-page":"1160","article-title":"A comparison of A103 and inhibin reac- tivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors","volume":"11","author":"Renshaw","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/dc.20310","article-title":"Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens","volume":"33","author":"Jalali","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00129039-200203000-00012","article-title":"Calretinin and inhibin are useful in sepa- rating adrenocortical neoplasms from pheochromocytomas","volume":"10","author":"Jorda","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0270","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.MP.0000073134.60541.E8","article-title":"The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study","volume":"16","author":"Zhang","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0275","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00000478-200002000-00006","article-title":"Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms","volume":"24","author":"Avery","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0280","first-page":"392","article-title":"Immunohistochemical analysis of 42 renal cell carcinomas and one oncocytoma with mono- and polyclonal antibodies against vimentin and cytokeratin","volume":"73","author":"Beham","year":"1989","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0285","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00000478-198708000-00007","article-title":"Low-grade renal cell carcinoma: a clinicopathologic study of 53 cases","volume":"11","author":"Medeiros","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0290","first-page":"99","article-title":"Coordinate expressions of cytok- eratins 7 and 20 defines unique subsets of carcinomas","volume":"3","author":"Wang","year":"1995","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/107327480601300103","article-title":"Pathology of liver metastases","volume":"13","author":"Centeno","year":"2006","journal-title":"Cancer Control"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0300","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<171::AID-CNCR24>3.0.CO;2-V","article-title":"Adenocarcinomas metastatic to the liver: the value of cytok- eratins 20 and 7 in the search for unknown primary tumors","volume":"85","author":"Tot","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0305","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1600-0463.2003.apm1111201.x","article-title":"The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis","volume":"111","author":"Tot","year":"2003","journal-title":"APMIS"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0310","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/modpathol.3880560","article-title":"Expression of thyroid tran- scription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar car- cinomas: an immunohistochemical evaluation of 67 cases","volume":"15","author":"Lau","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0315","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1309\/UMF715KRG2V198YD","article-title":"Usefulness of Cdx2 in sepa-rating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma","volume":"122","author":"Saad","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0320","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004347-200210000-00009","article-title":"Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas","volume":"21","author":"Ji","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0325","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1309\/550P-QLJX-D84W-F6DN","article-title":"Mucinous and nonmucinous bronchi- oloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies","volume":"116","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0330","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(20011115)92:10<2727::AID-CNCR1627>3.0.CO;2-B","article-title":"The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas","volume":"92","author":"Tot","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0335","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.humpath.2003.12.007","article-title":"Cytokeratin expression profile in gastric carcinomas","volume":"35","author":"Kim","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0340","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1309\/1NCM-46QX-3B5T-7XHR","article-title":"Cytokeratins 7, 17, and 20 reactivity in pan- creatic and ampulla of vater adenocarcinomas: percentage of positivity and distribution is affected by the cut-point threshold","volume":"115","author":"Goldstein","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0345","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1365-2559.2000.00801.x","article-title":"Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B","volume":"36","author":"Kaufmann","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00129039-200206000-00001","article-title":"Thyroid transcription factor-1: a review","volume":"10","author":"Lau","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0355","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/cncr.9048","article-title":"Use of thyroid tran- scription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens","volume":"93","author":"Chhieng","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0360","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1309\/CM20WA20RW3T600L","article-title":"Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens","volume":"121","author":"Simsir","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0365","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1309\/NL4Y-FHG8-2XBC-F9XH","article-title":"The value of thyroid tran- scription factor-1 in cytologic preparations as a marker for metastatic ade- nocarcinoma of lung origin","volume":"116","author":"Hecht","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0370","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.5858\/2003-127-1591-TUOERA","article-title":"The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver","volume":"127","author":"Nash","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0375","doi-asserted-by":"crossref","first-page":"338","DOI":"10.5858\/2005-129-338-UOIIDP","article-title":"Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcino- mas in the gastrointestinal tract","volume":"129","author":"O'Connell","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0380","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2559.1996.tb01396.x","article-title":"Immunohisto-chemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites","volume":"29","author":"Kaufmann","year":"1996","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0385","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1309\/QLV6-HH0H-UCTF-WEF6","article-title":"WT1, estrogen receptor, and prog- esterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids","volume":"117","author":"Lee","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0390","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1159\/000333931","article-title":"Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens","volume":"40","author":"Fiel","year":"1996","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0395","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0046-8177(89)90137-8","article-title":"Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin","volume":"20","author":"Wick","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0400","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/PAI.0b013e3181a75e6d","article-title":"Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemis- try performance","volume":"1","author":"Anderson","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0405","first-page":"7388","article-title":"Molecular classification of human carcinomas by use of gene expression signatures","volume":"61","author":"Su","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0410","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.seminoncol.2008.10.002","article-title":"Molecular classification of unknown primary cancer","volume":"36","author":"Bender","year":"2009","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0415","first-page":"229","article-title":"Carcinoma of unknown primary","volume":"1","author":"Varadhachary","year":"2007","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jmoldx.2011.04.004","article-title":"Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification","volume":"13","author":"Erlander","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0425","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmoldx.2010.11.001","article-title":"Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens","volume":"13","author":"Pillai","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0430","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1634\/theoncologist.2011-0466","article-title":"A second-generation microRNA-based assay for diagnosing tumor tissue origin","volume":"17","author":"Meiri","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0435","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1200\/JCO.2008.17.9762","article-title":"Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin","volume":"27","author":"Monzon","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0440","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/modpathol.2010.57","article-title":"Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin","volume":"23","author":"Rosenwald","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0445","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5858\/2006-130-465-MCOHCU","article-title":"Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay","volume":"130","author":"Ma","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0450","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nbt1392","article-title":"MicroRNAs accurately identify cancer tissue origin","volume":"26","author":"Rosenfeld","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0455","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jnci\/djt099","article-title":"Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology","volume":"105","author":"Greco","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1200\/JCO.2012.43.3755","article-title":"Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute","volume":"31","author":"Hainsworth","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0465","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv362","article-title":"Treatment algorithms based on tumor molecular profiling: the essence of precision medicine trials","volume":"108","author":"Le Tourneau","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0470","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jjco\/hyv122","article-title":"Current and future molecular profiling of cancer by next-generation sequencing","volume":"45","author":"Shibata","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0475","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International Cancer Genome Consortium. International network of cancer genome projects","volume":"464","author":"Hudson","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0480","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0485","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0490","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"International STI571 CML Study Group. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0495","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0500","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","article-title":"Emerging landscape of oncogenic signatures across human cancers","volume":"45","author":"Ciriello","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0505","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"Zack","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0510","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0515","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1998.16.8.2659","article-title":"Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2\/neu monoclonal antibody plus cisplatin in patients with HER2\/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment","volume":"16","author":"Pegram","year":"1998","journal-title":"J Clin Oncol"},{"issue":"suppl 5","key":"10.1016\/j.cancergen.2016.08.004_bib0520","first-page":"S579","article-title":"Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer","volume":"5","author":"Savas","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.cancergen.2016.08.004_bib0525","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jamaoncol.2014.216","article-title":"Comprehensive genomic profiling of carcinoma of unknown primary site. New routes to targeted therapies","volume":"1","author":"Ross","year":"2015","journal-title":"JAMA Oncol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776216302289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:42Z","timestamp":1761896502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776216302289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":104,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2210776216302289"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.08.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A practical approach to liver metastasis from unknown primary cancer: What surgeons need to know","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}